Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Accounts receivable, allowance	$ (24,426)	$ (21,647)
Deferred financing costs	$ (13,882)	$ (10,578)
Common shares, par value (in USD per share)	$ 0.01	$ 0.01
Common shares, shares authorized (in shares)	500,000,000	500,000,000
Common shares, shares issued (in shares)	284,265,041	283,699,120
Common shares, shares outstanding (in shares)	284,265,041	283,699,120